Open Menu Close Menu

In its seventh iteration, the Alzheimer’s Association is pleased to announce the Part the Cloud Translational Research Funding initiative to increase the research efforts in Phase I and Phase II (Proof of Concept) clinical trials directed towards Alzheimer’s disease and related dementias internationally.This new grant mechanism aims to fill the gap in Alzheimer’s disease drug development by providing support for early phase studies of potential Alzheimer’s therapeutics or validation of biological markers of disease progression.